Please enable Javascript
Kerri Fitzgerald
Kerri Fitzgerald
Articles by Kerri Fitzgerald
As Liver Cancer Rates, Mortality Continue to Rise, Advocacy and Policy Efforts Are Important
Kerri Fitzgerald
ISGIO 2023
|
March 19, 2025
While liver cancer is the third deadliest cancer in the world, there are still unmet needs regarding the disease.
Read More
FDA Approves First Targeted Treatment for Rare Bile Duct Cancer
Kerri Fitzgerald
Bile Duct Cancer
|
April 22, 2020
The U.S. Food and Drug Administration approved Pemazyre™ (pemigatinib), the first targeted treatment for adults with ...
Read More
FDA Approves New Combination for BRAF V600E-Mutated Colorectal Cancer
Kerri Fitzgerald
Colorectal Cancer
|
March 19, 2025
The U.S. Food and Drug Administration (FDA) approved Braftovi® (encorafenib) in combination with cetuximab for ...
Read More
FDA Approves New Liver Cancer Combo for Previously Treated Patients
Kerri Fitzgerald
Liver Cancer
|
March 19, 2025
The U.S. Food and Drug Administration approved Opdivo® (nivolumab) in combination with Yervoy® (ipilimumab) for ...
Read More
GI Bleeding Increases Colorectal Cancer Risk in Patients With Atrial Fibrillation Receiving Anticoagulants
Kerri Fitzgerald
Colorectal Cancer
|
February 11, 2020
In patients with atrial fibrillation (AF) who receive anticoagulants, lower gastrointestinal (GI) bleeding is associated ...
Read More
Treatment for H. Pylori Reduces Gastric Cancer Risk, Even in Those With Family History
Kerri Fitzgerald
Gastric Cancer
|
March 19, 2025
Patients with Helicobacter pylori (H. pylori) infection and a first-degree family history of gastric cancer had a ...
Read More
Is This Bacteria the Cause for the Increase in Colorectal Cancer Cases in Younger Patients?
Kerri Fitzgerald
Colorectal Cancer
|
January 29, 2020
A study found that the oral bacterium Fusobacterium nucleatum (F. nuc) presents in a greater number of colorectal ...
Read More
FDA Approves Ayvakit™ for Gastrointestinal Cancer
Kerri Fitzgerald
Gastric Cancer
|
March 19, 2025
The U.S. Food and Drug Administration approved Ayvakit™ (avapritinib) for adults with unresectable or metastatic ...
Read More
New CRC Screening Guidelines Have Boosted Adherence for Younger Patients
Kerri Fitzgerald
Colorectal Cancer
|
March 19, 2025
Reducing the recommended screening age for colorectal cancer (CRC) has increased screening adherence in patients aged 45 ...
Read More
ACA Has Impacted Colorectal Cancer Diagnosis, Treatment in Younger Adults
Kerri Fitzgerald
Colorectal Cancer
|
March 19, 2025
The dependent coverage expansion provision under the Affordable Care Act (ACA) has led to earlier diagnosis and better ...
Read More
Colorectal and Pancreatic Cancer Rates Have Increased in the Past 30 Years
Kerri Fitzgerald
Pancreatic Cancer
|
March 19, 2025
A large study spanning 195 countries found that colorectal and pancreatic cancer rates have increased by 10% between ...
Read More
Improving Specialist Referral Times for Patients at Low Risk for Colorectal Cancer
Kerri Fitzgerald
Colorectal Cancer
|
March 19, 2025
Patients with colorectal cancer (CRC) who present with no alarming symptoms may encounter a longer time to referral of a ...
Read More
Triplet Pancreatic Cancer Regimen Demonstrates “Encouraging” Survival
Kerri Fitzgerald
Pancreatic Cancer
|
March 19, 2025
The addition of cisplatin to Abraxane® (nab-paclitaxel) and Gemzar® (gemcitabine) improved survival in patients with ...
Read More
Circulating Tumor DNA Predicts Colorectal Cancer Relapse
Kerri Fitzgerald
Colorectal Cancer
|
October 8, 2019
Circulating tumor DNA detected through liquid biopsy is an independent predictor of patients with colorectal cancer ...
Read More
Fungus in the Pancreas Leads to Pancreatic Cancer
Kerri Fitzgerald
Pancreatic Cancer
|
March 19, 2025
A study published in Nature found that the movement of certain fungi from the gut to the pancreas can increase the risk ...
Read More
Opdivo® Improves Survival Over Chemo in Esophageal Cancer
Kerri Fitzgerald
Esophageal Cancer
|
March 19, 2025
Results from the multicenter, randomized, open-label, global, phase III ATTRACTION-3 trial presented at the ESMO ...
Read More
Anti-EGFR Therapy Induces Response in Patients with BRAF non-V600 Metastatic Colorectal Cancer
Kerri Fitzgerald
Colorectal Cancer
|
September 12, 2019
Patients with metastatic colorectal cancer (CRC) harboring a subset of non-V600 mutations in the BRAF gene were more ...
Read More
Rates of Colorectal Cancer on the Rise in Younger Adults in Wealthier Countries
Kerri Fitzgerald
Colorectal Cancer
|
March 19, 2025
The incidence of colorectal cancer (CRC) has increased in young adults in nine high-income countries spanning three ...
Read More
This Diabetes Drug Increases the Risk of Pancreatic Cancer
Kerri Fitzgerald
Pancreatic Cancer
|
March 19, 2025
Patients with type 2 diabetes who are treated with dipeptidyl peptidase-4 (DPP-4) inhibitors are at risk for developing ...
Read More
Text Message Reminder Improves Colonoscopy Adherence
Kerri Fitzgerald
Colorectal Cancer
|
August 28, 2019
A text message reminder one week prior to a scheduled colonoscopy significantly decreased the number of patients who did ...
Read More
Load More